Literature DB >> 25755524

Combination Therapy in Severe Alcoholic Hepatitis-Doesn't Really Work.

Ajay Duseja1.   

Abstract

Entities:  

Year:  2013        PMID： 25755524      PMCID： PMC4216930          DOI： 10.1016/j.jceh.2013.11.005

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  8 in total

1.  Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone.

Authors:  Philippe Mathurin; Marcelle Abdelnour; Marie-José Ramond; Nicolas Carbonell; Laetitia Fartoux; Lawrence Serfaty; Dominique Valla; Raoul Poupon; Jean-Claude Chaput; Sylvie Naveau
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

2.  Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.

Authors:  Philippe Mathurin; Alexandre Louvet; Alain Duhamel; Pierre Nahon; Nicolas Carbonell; Jérôme Boursier; Rodolphe Anty; Emmanuel Diaz; Dominique Thabut; Romain Moirand; Didier Lebrec; Christophe Moreno; Nathalie Talbodec; Thierry Paupard; Sylvie Naveau; Christine Silvain; Georges-Philippe Pageaux; Rodolphe Sobesky; Valérie Canva-Delcambre; Sébastien Dharancy; Julia Salleron; Thong Dao
Journal:  JAMA       Date:  2013-09-11       Impact factor: 56.272

3.  Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score.

Authors:  E H Forrest; C D J Evans; S Stewart; M Phillips; Y H Oo; N C McAvoy; N C Fisher; S Singhal; A Brind; G Haydon; J O'Grady; C P Day; P C Hayes; L S Murray; A J Morris
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

4.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

Review 5.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

6.  The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.

Authors:  Alexandre Louvet; Sylvie Naveau; Marcelle Abdelnour; Marie-José Ramond; Emmanuel Diaz; Laetitia Fartoux; Sébastien Dharancy; Frédéric Texier; Antoine Hollebecque; Lawrence Serfaty; Emmanuel Boleslawski; Pierre Deltenre; Valérie Canva; François-René Pruvot; Philippe Mathurin
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

7.  APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF).

Authors:  Ajay Duseja; Narendra S Choudhary; Sachin Gupta; Radha Krishan Dhiman; Yogesh Chawla
Journal:  J Dig Dis       Date:  2013-09       Impact factor: 2.325

8.  Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial.

Authors:  R L Carithers; H F Herlong; A M Diehl; E W Shaw; B Combes; H J Fallon; W C Maddrey
Journal:  Ann Intern Med       Date:  1989-05-01       Impact factor: 25.391
  8 in total
  1 in total

Review 1.  New treatment options for alcoholic hepatitis.

Authors:  Saggere Muralikrishna Shasthry; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.